Clinical Trials Logo

Clinical Trial Summary

This is a randomized, double-blind, placebo-controlled, crossover, multicenter study of AX-8 in participants with unexplained or refractory chronic cough designed to evaluate the effectiveness of AX-8 in reducing cough frequency.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04866563
Study type Interventional
Source Axalbion SA
Contact Chief Medical Officer
Phone +41 22 534 94 80
Email [email protected]
Status Not yet recruiting
Phase Phase 2
Start date June 2021
Completion date April 2022

See also
  Status Clinical Trial Phase
Completed NCT01432730 - A Study to Assess the Efficacy of Gefapixant (MK-7264/AF-219), in Participants With Chronic Cough (MK-7264-006) Phase 2
Not yet recruiting NCT01413698 - Cough Count Validation N/A
Completed NCT03639727 - Cough in Eastern and Central Finland N/A
Completed NCT03696108 - A Study of Gefapixant (MK-7264) in Japanese Adult Participants With Refractory or Unexplained Chronic Cough (MK-7264-038) Phase 3
Recruiting NCT03638063 - ATP and Capsaicin Cough Provocation Test in Chronic Cough and Bronchiectasis
Completed NCT03172130 - Sham CPAP vs. Straight CPAP for Chronic Cough N/A
Completed NCT03622216 - A Dose Escalation Study of Bradanicline in Refractory Chronic Cough Phase 2
Completed NCT01297790 - Cough Responses to Tussive Agents in Health and Disease N/A
Completed NCT01865422 - French Linguistic and Metric Validations of Parent-proxy QOL Chronic Cough Specific Questionnaire (PC-QOL) N/A
Recruiting NCT04525885 - A Study of Gefapixant (MK-7264) in Adult Participants With Chronic Cough (MK-7264-030)-China Extension Phase 3
Recruiting NCT03787511 - Chronic Cough and Small Fiber Neuropathy N/A
Terminated NCT03864328 - A Phase 2b Study of Inhaled RVT-1601 for the Treatment of Persistent Cough in IPF Phase 2
Not yet recruiting NCT01807832 - The Use of Capsaicin Challenge for Diagnosis, Monitoring and Follow-up of Chronic Cough. N/A
Completed NCT03482713 - Study of Gefapixant (MK-7264) in Adult Japanese Participants With Unexplained or Refractory Chronic Cough (MK-7264-033) Phase 2
Completed NCT03449147 - A Study of Gefapixant (MK-7264) in Adult Participants With Chronic Cough (MK-7264-030) Phase 3
Completed NCT03449134 - Phase 3 Study of Gefapixant (MK-7264) in Adult Participants With Chronic Cough (MK-7264-027) Phase 3
Completed NCT01566968 - Novel Endpoints in Cough Challenge Testing N/A
Not yet recruiting NCT04694963 - A Multi-center Study to Determine the Prevalence and Influence of Pertussis on Subacute Cough in Shenzhen
Recruiting NCT01858584 - Prospective, Comparative, Randomized, Controlled Trial on the Efficacy of the Treatment of Gastroesophageal Reflux Infant With Magnesium Alginate N/A
Completed NCT01252225 - Lidocaine: Effect of Lidocaine in Chronic Cough Phase 4